Drugs / Codonopsis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05613465 | Oct 2022 → Oct 2024 | pancreatic adenocarcinoma | Zhejiang Provincial People's Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Codonopsis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05613465 ↗ |
| Known as | Codonopsis pilosula Nnannf | “Codonopsis pilosula Nnannf is oral liquid, which has been approved for listing” NCT05613465 ↗ |
| Route | Oral | “Codonopsis pilosula Nnannf is oral liquid, which has been approved for listing” NCT05613465 ↗ |